Clinical Trial Update: Post Marketing Study to Evaluate the Efficacy and Safety of Solifenacin in Patients With OAB (Overactive Bladder) After TURP (Trans-urethral Resection of Prostate) or PVP (Photoselective Vaporization of Prostate) [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study assessing the efficacy and safety of solifenacin for overactive bladder in patients after prostate surgery (TURP or PVP) has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Solifenacin (solifenacin)

Snippet

Sponsor: Astellas Pharma Korea, Inc. | Conditions: Overactive Bladder, Benign Prostate Hyperplasia | Phase 4 | Status: COMPLETED